17-beta-hydroxysteroid dehydrogenase deficiency genotyping: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{Abdulkerim}}
{{CMG}}; {{AE}} {{Abdulkerim}}
==Overview==
==Overview==
17 beta hydroxysteroid dehydrogenase deficiency is a condition with [[genotypically]] male and [[phenotypically]] female characterstics. There has been no [[phenotype]] to [[genotype correlation]]
*17 beta hydroxysteroid dehydrogenase deficiency is a condition with [[genotypically]] male and [[phenotypically]] female characteristics. There has been no [[phenotype]] to [[genotype correlation]].
 
==Genotyping==
==Genotyping==
*17 beta hydroxysteroid dehydrogenase deficiency is a condition with [[genotypically]] male and [[phenotypically]] female characterstics. There has been no [[phenotype]] to [[genotype correlation]].<ref name="pmid20689261">{{cite journal| author=George MM, New MI, Ten S, Sultan C, Bhangoo A| title=The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency. | journal=Horm Res Paediatr | year= 2010 | volume= 74 | issue= 4 | pages= 229-40 | pmid=20689261 | doi=10.1159/000318004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20689261  }} </ref>
*17 beta hydroxysteroid dehydrogenase deficiency is a condition with [[genotypically]] male and [[phenotypically]] female characterstics. There has been no [[phenotype]] to [[genotype correlation]].<ref name="pmid20689261">{{cite journal| author=George MM, New MI, Ten S, Sultan C, Bhangoo A| title=The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency. | journal=Horm Res Paediatr | year= 2010 | volume= 74 | issue= 4 | pages= 229-40 | pmid=20689261 | doi=10.1159/000318004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20689261  }} </ref>

Revision as of 07:28, 7 October 2022

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency genotyping On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency genotyping

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency genotyping

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency genotyping

17-beta-hydroxysteroid dehydrogenase deficiency genotyping in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency genotyping

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency genotyping

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]

Overview

Genotyping

References

  1. George MM, New MI, Ten S, Sultan C, Bhangoo A (2010). "The clinical and molecular heterogeneity of 17βHSD-3 enzyme deficiency". Horm Res Paediatr. 74 (4): 229–40. doi:10.1159/000318004. PMID 20689261.

Template:WH Template:WS